— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5305 articles 2881 bullish 1234 bearish Full Index →
ODD Investors Have Opportunity to Lead ODDITY Tech Ltd. Securities Fraud Lawsuit

ODD Investors Have Opportunity to Lead ODDITY Tech Ltd. Securities Fraud Lawsuit

NEW YORK, March 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"). A...
bearish ATY PRNewswire 9h ago
EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery W

EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform

Hoth Therapeutics Inc. (NASDAQ:HOTH) announced Thursday that it has launched OpenClaw, an artificial intelligence-enabled platform aimed at...
📰

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

PHILADELPHIA, March 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company...
📰

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat...
📰

Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

HOUSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and...
Czech National Bank Increases Position in Stryker Corporatio

Czech National Bank Increases Position in Stryker Corporation $SYK

Czech National Bank boosted its position in Stryker Corporation (NYSE:SYK – Free Report) by 3.9% in the 4th quarter, according to its most...
Czech National Bank Increases Position in Stryker Corporatio

Czech National Bank Increases Position in Stryker Corporation $SYK

Czech National Bank boosted its position in Stryker Corporation (NYSE:SYK – Free Report) by 3.9% in the 4th quarter, according to its most...
📰
Benzinga Expands Global Reach With Mirae Asset Securities Re

Benzinga Expands Global Reach With Mirae Asset Securities Relationship to Deliver U.S. Market Intelligence to Korean Investors

DETROIT and SEOUL, South Korea , March 26, 2026 /PRNewswire/ -- Benzinga, the largest financial news provider in North America, is excited to...
📰

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical...
Hyperion DeFi Reports 4Q and FY 2025 Financial Results with

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

Five Diversified, Ramping DeFi Business Lines Delivered Growth Exceeding Q4 Guidance
📰

MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected to reach target enrollment (n=300) in April 2026, with topline results expected in the...
📰

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Antwerp, Belgium, March 26, 2026 – Agomab Therapeutics NV (NASDAQ:AGMB) ("'Agomab'"), a clinical-stage biopharmaceutical company focused on...
📰

Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results

– Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen in broad patient...
📰

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Carderock Capital Management Inc. Has $13.09 Million Stake i

Carderock Capital Management Inc. Has $13.09 Million Stake in Eli Lilly and Company $LLY

Carderock Capital Management Inc. boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.2% during the fourth quarter,...
Carderock Capital Management Inc. Has $13.09 Million Stake i

Carderock Capital Management Inc. Has $13.09 Million Stake in Eli Lilly and Company $LLY

Carderock Capital Management Inc. boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.2% during the fourth quarter,...
📰
Bain & Company announces expansion of lead global manage

Bain & Company announces expansion of lead global management consulting partnership with Palantir to bring world industry-leading AI transformation capabilities to clients

Deepening of collaboration amid rapidly growing demand further extends client companies' access to Bain and Palantir joint expertise in accelerating...
Sungrow and ENEVO Group Sign Landmark 1GWh Energy Storage Ag

Sungrow and ENEVO Group Sign Landmark 1GWh Energy Storage Agreement to Power Romania's Energy Transition

MUNICH, March 26, 2026 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system (ESS) provider, has announced the signing of...
📰

Innovent Announces 2025 Annual Results and Business Updates

From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and...
📰

Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
DAVENPORT & Co LLC Purchases 155,334 Shares of Ionis Pharmac

DAVENPORT & Co LLC Purchases 155,334 Shares of Ionis Pharmaceuticals, Inc. $IONS

DAVENPORT & Co LLC increased its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 248.3% in the fourth...
DAVENPORT & Co LLC Purchases 155,334 Shares of Ionis Pharmac

DAVENPORT & Co LLC Purchases 155,334 Shares of Ionis Pharmaceuticals, Inc. $IONS

DAVENPORT & Co LLC increased its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 248.3% in the fourth...
156,015 Shares in Danaher Corporation $DHR Acquired by Defen

156,015 Shares in Danaher Corporation $DHR Acquired by Defender Capital LLC.

Defender Capital LLC. acquired a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 4th quarter, according to the...
156,015 Shares in Danaher Corporation $DHR Acquired by Defen

156,015 Shares in Danaher Corporation $DHR Acquired by Defender Capital LLC.

Defender Capital LLC. acquired a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 4th quarter, according to the...
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20

Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Shares of Navan Inc (NASDAQ:NAVN) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results...
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20

Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Shares of Navan Inc (NASDAQ:NAVN) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results...
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20

Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Shares of Navan Inc (NASDAQ:NAVN) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results...
📰

Medicus Pharma Ltd. GAAP EPS of $2.74

Czech National Bank Buys 955 Shares of McKesson Corporation

Czech National Bank Buys 955 Shares of McKesson Corporation $MCK

Czech National Bank boosted its position in shares of McKesson Corporation (NYSE:MCK – Free Report) by 3.0% during the fourth quarter,...
Czech National Bank Buys 955 Shares of McKesson Corporation

Czech National Bank Buys 955 Shares of McKesson Corporation $MCK

Czech National Bank boosted its position in shares of McKesson Corporation (NYSE:MCK – Free Report) by 3.0% during the fourth quarter,...
Pfizer Inc. $PFE Stake Lifted by First Bank & Trust

Pfizer Inc. $PFE Stake Lifted by First Bank & Trust

First Bank & Trust lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 21.5% during the fourth quarter, according to its...
Pfizer Inc. $PFE Stake Lifted by First Bank & Trust

Pfizer Inc. $PFE Stake Lifted by First Bank & Trust

First Bank & Trust lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 21.5% during the fourth quarter, according to its...
Rönesans Holding anuncia una nueva asociación global

Rönesans Holding anuncia una nueva asociación global

Asociación estratégica firmada entre Rönesans y SJ Group para ayudar a continuar entregando la Zona Industrial DAPEK ESTAMBUL, 26 de marzo de 2026...
Czech National Bank Increases Stake in Medtronic PLC $MDT

Czech National Bank Increases Stake in Medtronic PLC $MDT

Czech National Bank boosted its stake in shares of Medtronic PLC (NYSE:MDT – Free Report) by 3.9% during the 4th quarter, according to the...
Czech National Bank Increases Stake in Medtronic PLC $MDT

Czech National Bank Increases Stake in Medtronic PLC $MDT

Czech National Bank boosted its stake in shares of Medtronic PLC (NYSE:MDT – Free Report) by 3.9% during the 4th quarter, according to the...
First Bank & Trust Invests $632,000 in Merck & Co., Inc. $MR

First Bank & Trust Invests $632,000 in Merck & Co., Inc. $MRK

First Bank & Trust bought a new position in Merck & Co., Inc. (NYSE:MRK – Free Report) during the fourth quarter, according to the...
First Bank & Trust Invests $632,000 in Merck & Co., Inc. $MR

First Bank & Trust Invests $632,000 in Merck & Co., Inc. $MRK

First Bank & Trust bought a new position in Merck & Co., Inc. (NYSE:MRK – Free Report) during the fourth quarter, according to the...
Czech National Bank Raises Stock Position in Merck & Co., In

Czech National Bank Raises Stock Position in Merck & Co., Inc. $MRK

Czech National Bank raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.2% during the fourth quarter,...
Czech National Bank Raises Stock Position in Merck & Co., In

Czech National Bank Raises Stock Position in Merck & Co., Inc. $MRK

Czech National Bank raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.2% during the fourth quarter,...
4,610 Shares in Danaher Corporation $DHR Purchased by First

4,610 Shares in Danaher Corporation $DHR Purchased by First Bank & Trust

First Bank & Trust bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the fourth quarter, according to...
4,610 Shares in Danaher Corporation $DHR Purchased by First

4,610 Shares in Danaher Corporation $DHR Purchased by First Bank & Trust

First Bank & Trust bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the fourth quarter, according to...
E. Ohman J or Asset Management AB Makes New $912,000 Investm

E. Ohman J or Asset Management AB Makes New $912,000 Investment in Insmed, Inc. $INSM

E. Ohman J or Asset Management AB purchased a new stake in Insmed, Inc. (NASDAQ:INSM – Free Report) during the fourth quarter, according to the...
Cullen Investment Group LTD. Makes New $3.70 Million Investm

Cullen Investment Group LTD. Makes New $3.70 Million Investment in Becton, Dickinson and Company $BDX

Cullen Investment Group LTD. purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the fourth...
« Prev 1 2 3 44 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms